Bradycardia after high - dose intravenous methylprednisolone therapy .
In 5 consecutive patients with rheumatoid arthritis who received intravenous high - dose methylprednisolone ( MP ) therapy ( 1 g daily for 2 or 3 consecutive days ) , a decline in pulse rate was observed , most pronounced on day 4 .
In one of the 5 patients the bradycardia was associated with complaints of substernal pressure .
Reversal to normal heart rate was found on day 7 .
Electrocardiographic registrations showed sinus bradycardia in all cases .
No significant changes in plasma concentrations of electrolytes were found .
Careful observation of patients receiving high - dose MP is recommended .
High - dose MP may be contraindicated in patients with known heart disease .